First product through EU's advanced therapies regulation gets approval renewed
The EMA's CHMP has renewed the marketing authorization for TiGenix's ChondroCelect in the EU and EEA.
The EMA's CHMP has renewed the marketing authorization for TiGenix's ChondroCelect in the EU and EEA.